GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Medicine Co Ltd (SHSE:600216) » Definitions » EV-to-FCF

Zhejiang Medicine Co (SHSE:600216) EV-to-FCF : 52.57 (As of Dec. 12, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Zhejiang Medicine Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Zhejiang Medicine Co's Enterprise Value is ¥14,874 Mil. Zhejiang Medicine Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ¥283 Mil. Therefore, Zhejiang Medicine Co's EV-to-FCF for today is 52.57.

The historical rank and industry rank for Zhejiang Medicine Co's EV-to-FCF or its related term are showing as below:

SHSE:600216' s EV-to-FCF Range Over the Past 10 Years
Min: -625.53   Med: -20.78   Max: 296.09
Current: 52.29

During the past 13 years, the highest EV-to-FCF of Zhejiang Medicine Co was 296.09. The lowest was -625.53. And the median was -20.78.

SHSE:600216's EV-to-FCF is ranked worse than
74.09% of 552 companies
in the Drug Manufacturers industry
Industry Median: 25.86 vs SHSE:600216: 52.29

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-12), Zhejiang Medicine Co's stock price is ¥16.92. Zhejiang Medicine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥1.020. Therefore, Zhejiang Medicine Co's PE Ratio (TTM) for today is 16.59.


Zhejiang Medicine Co EV-to-FCF Historical Data

The historical data trend for Zhejiang Medicine Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Medicine Co EV-to-FCF Chart

Zhejiang Medicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -97.48 17.37 78.88 -23.38 -59.81

Zhejiang Medicine Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -80.74 -59.81 -72.57 -149.98 55.52

Competitive Comparison of Zhejiang Medicine Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Medicine Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Medicine Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Medicine Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Zhejiang Medicine Co's EV-to-FCF falls into.



Zhejiang Medicine Co EV-to-FCF Calculation

Zhejiang Medicine Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=14874.014/282.962
=52.57

Zhejiang Medicine Co's current Enterprise Value is ¥14,874 Mil.
Zhejiang Medicine Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥283 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Medicine Co  (SHSE:600216) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Zhejiang Medicine Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=16.92/1.020
=16.59

Zhejiang Medicine Co's share price for today is ¥16.92.
Zhejiang Medicine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.020.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Zhejiang Medicine Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Zhejiang Medicine Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Medicine Co Business Description

Traded in Other Exchanges
N/A
Address
Comprehensive Building, No. 398 Mahuan Road, 3rd Floor, Building A, Binhai New City, Shaoxing, CHN, 312366
Zhejiang Medicine Co Ltd is a china-based pharmaceutical company. The company manufactures fat-soluble vitamins, vitamins, quinolones, and antibiotic-resistant antibiotics, vitamin E, natural vitamin E, beta-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin.
Executives
Zhu Jin Lin senior management
Chu Zhen Hua Director
Liang Bi Rong Director
Yu Yu Qing Director
Ping Jian Hong senior management
An Yong Bin senior management
Wang Xiao Ping senior management
Liang Li Ping senior management
Li Qi Rong senior management
Zhu Shao Ming Supervisors
Wang Hong Wei senior management
Zhang Ding Feng senior management
Ma Wen Xin Director
Zhao Jun Xing senior management
Lv Yong Hui Director

Zhejiang Medicine Co Headlines

No Headlines